The Problem With Residual Symptoms for Patients With MDD: Focus on Insomnia
Join us for a symposium on major depressive disorder (MDD) designed to encourage the exchange of ideas between leaders in the field and attendees. This presentation will include a discussion of typical first-line treatments for MDD and how these traditional therapies may result in suboptimal treatment response and adverse side effects; the importance of regularly assessing/screening for treatment response to identify residual symptoms, such as insomnia; and how the presence of residual symptoms, such as insomnia, may lead to poor long-term depression treatment response and decreased quality of life.
Moderator:
Leslie L. Citrome, MD, MPH
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York
Faculty:
Joseph F. Goldberg, MD
Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York
Faculty:
Paul P. Doghramji, MD, FAAFP
Senior Family Physician
Collegeville Family Practice
Collegeville, Pennsylvania
Earn free 0.50 AMA PRA Category 1 Credit™. Access for credit will be shared at the end of this live event.
Click the link to view the Accreditation and Disclosure details before participating: https://www.medscape.org/viewarticle/1002477
Supported by an independent educational grant from Janssen Pharmaceuticals.